ImmunityBio, Inc.
NASDAQ:IBRX
2.56 (USD) • At close January 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 265.453 | 104.641 | 181.101 | 34.915 | 15.508 | 16.821 | 23.872 | 8.083 | 175.908 | 59.104 | 0.35 |
| Short Term Investments
| 1.009 | 2.543 | 136.015 | 61.146 | 36.144 | 57.328 | 104.28 | 190.838 | 118.31 | 0 | 0 |
| Cash and Short Term Investments
| 266.462 | 107.184 | 317.116 | 96.061 | 51.652 | 74.149 | 128.152 | 198.921 | 294.218 | 59.104 | 0.35 |
| Net Receivables
| 3.168 | 1.89 | 1.333 | 0 | 0.303 | 12.168 | 1.258 | 0 | 1.774 | 0.145 | 0.38 |
| Inventory
| 0 | 26.354 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 24.454 | 31.503 | 15.898 | 9.196 | 3.802 | 2.455 | 3.048 | 3.556 | 1.548 | 0.124 | 0.248 |
| Total Current Assets
| 294.084 | 140.577 | 334.347 | 111.713 | 55.757 | 88.772 | 132.458 | 205.145 | 297.54 | 59.373 | 0.978 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 182.683 | 189.447 | 119.167 | 90.679 | 72.23 | 76.885 | 76.726 | 19.268 | 6.147 | 0.211 | 0.013 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 17.093 | 20.003 | 1.42 | 1.463 | 12.074 | 12.085 | 2.826 | 5.086 | 7.292 | 0.835 | 0.863 |
| Goodwill and Intangible Assets
| 17.093 | 20.003 | 1.42 | 1.463 | 12.074 | 12.085 | 2.826 | 5.086 | 7.292 | 0.835 | 0.863 |
| Long Term Investments
| 0.891 | 5.7 | 6.775 | 10.447 | 10.929 | 14.38 | 38.279 | 87.75 | 55.135 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 3.739 | 3.233 | -8.5 | 0 | 0.11 | 0.391 | 0 | 0 |
| Other Non-Current Assets
| 9.701 | 6.629 | 7.201 | 3.34 | -11.1 | -1.672 | 0.151 | 0.137 | 0.344 | 0.409 | 0.249 |
| Total Non-Current Assets
| 210.368 | 221.779 | 134.563 | 109.668 | 87.366 | 93.178 | 117.982 | 112.351 | 69.309 | 1.455 | 1.125 |
| Total Assets
| 504.452 | 362.356 | 468.91 | 221.381 | 143.123 | 181.95 | 250.44 | 317.496 | 366.849 | 60.828 | 2.103 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 9.195 | 21.016 | 11.418 | 11.51 | 1.749 | 2.793 | 5.865 | 4.045 | 2.085 | 1.131 | 1.501 |
| Short Term Debt
| 5.244 | 434.551 | 305.258 | 5.015 | 3.963 | 0.965 | 0.618 | 0.534 | -0.228 | 0.265 | 1.76 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0.1 | 0 | 0 | 0 | 0 | 0.52 | 0.197 | 0.228 | 0.521 | 0.573 |
| Other Current Liabilities
| 43.844 | 45.294 | 52.319 | 51.609 | 5.847 | 23.502 | 13.865 | 7.777 | 4.063 | -0.033 | -1.188 |
| Total Current Liabilities
| 58.283 | 500.861 | 368.995 | 68.134 | 11.559 | 27.26 | 20.868 | 12.553 | 6.148 | 2.405 | 4.998 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 721.479 | 289.222 | 380.485 | 270.532 | 21.77 | 5.945 | 6.65 | 7.676 | 4.936 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 10.885 | 0 | 0.166 | 0.187 | 0.228 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0.162 | 0.17 | 3.233 | 0 | 0.498 | 0.996 | 1.165 | 0 | 0 |
| Other Non-Current Liabilities
| 310.627 | 22.093 | -36.819 | 1.205 | -10.885 | 2.739 | 3.414 | 2.666 | -1.395 | 0.521 | 2.352 |
| Total Non-Current Liabilities
| 1,032.106 | 311.315 | 343.828 | 271.737 | 10.885 | 8.684 | 10.728 | 11.525 | 4.706 | 1.917 | 3.834 |
| Total Liabilities
| 1,090.389 | 812.176 | 712.823 | 339.871 | 22.444 | 35.944 | 31.596 | 24.078 | 10.854 | 2.405 | 4.998 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.067 | 0.042 | 0.04 | 0.038 | 0.01 | 0.008 | 0.008 | 0.008 | 0.008 | 0.003 | 0.002 |
| Retained Earnings
| -2,961.684 | -2,378.488 | -1,961.921 | -1,615.131 | -662.191 | -594.981 | -498.713 | -387.063 | -250.376 | -12.741 | -6.528 |
| Accumulated Other Comprehensive Income/Loss
| 0.01 | 0.183 | 0.004 | 0.122 | -0.105 | -0.267 | -0.381 | -0.284 | -0.192 | -0.046 | -0.009 |
| Other Total Stockholders Equity
| 2,374.62 | 1,930.936 | 1,719.704 | 1,495.163 | 782.965 | 741.246 | 717.93 | 680.757 | 606.555 | 71.207 | 3.64 |
| Total Shareholders Equity
| -586.987 | -447.327 | -242.173 | -119.808 | 120.679 | 146.006 | 218.844 | 293.418 | 355.995 | 58.423 | -2.895 |
| Total Equity
| -585.937 | -449.82 | -243.913 | -118.49 | 124.333 | 133.688 | 218.844 | 293.418 | 355.995 | 58.423 | -2.895 |
| Total Liabilities & Shareholders Equity
| 504.452 | 362.356 | 468.91 | 221.381 | 143.123 | 181.95 | 250.44 | 317.496 | 366.849 | 60.828 | 2.103 |